Sabina C. Grund, Kunibert Hanusch, Hans Uwe Wolf: Arsenic and Arsenic Compounds. W: Ullmann’s Encyclopedia of Industrial Chemistry. VCH-Wiley, 2005. DOI: 10.1002/14356007.a03_113. Brak numerów stron w książce
Papatheodorou G.N., Solin S.A. Vibrational excitations of As2O3. I. Disordered phases. „Phys. Rev. B”. 13 (4), s. 1741–1751, 1976. DOI: 10.1103/PhysRevB.13.1741.
Flynn E.J., Solin S.A., Papatheodorou G.N. Vibrational excitations of As2O3. II. Crystalline phases. „Phys. Rev. B”. 13 (4), s. 1752–1758, 1976. DOI: 10.1103/PhysRevB.13.1752.
PierreP.BobéPierreP. i inni, Arsenic trioxide: A promising novel therapeutic agent for lymphoproliferative and autoimmune syndromes in MRL/lpr mice, „Blood”, 108 (13), 2006, s. 3967–3975, DOI: 10.1182/blood-2006-04-020610, PMID: 16926289.
S.L.S.L.SoignetS.L.S.L. i inni, United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia, „Journal of Clinical Oncology”, 19 (18), 2001, s. 3852–3860, DOI: 10.1200/JCO.2001.19.18.3852, PMID: 11559723.
PierreP.BobéPierreP. i inni, Arsenic trioxide: A promising novel therapeutic agent for lymphoproliferative and autoimmune syndromes in MRL/lpr mice, „Blood”, 108 (13), 2006, s. 3967–3975, DOI: 10.1182/blood-2006-04-020610, PMID: 16926289.
S.L.S.L.SoignetS.L.S.L. i inni, United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia, „Journal of Clinical Oncology”, 19 (18), 2001, s. 3852–3860, DOI: 10.1200/JCO.2001.19.18.3852, PMID: 11559723.